A study to assess the effect of Resveratrol and Copper in reducing toxic side-effects of chemotherapy in patients with advanced mouth cancer.
Not Applicable
- Conditions
- Health Condition 1: null- Operable stage IV squamous cell carcinoma of buccal mucosa patients planned for surgery who have not received any prior treatment.
- Registration Number
- CTRI/2018/03/012459
- Lead Sponsor
- TMC Research Administrative Council
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Male or female patients 18 years and above.
2. Patients who have given written informed consent
3. Patients with performance status of 0,1 or 2 (ECOG scale)
4. Treatment naïve operable stage IV squamous cell carcinoma of buccal mucosa patients planned for surgery.
Exclusion Criteria
Medical comorbidities like hypertensive, diabetes mellitus, HbsAg and HIV positive, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the effect of R-Cu on serum and tumour tissue levels of inflammatory cytokines and circulating chromatin at pre-defined time points in patients with operable stage IV squamous cell carcinoma of buccal mucosa prior to surgery.Timepoint: 2 weeks prior to surgery (Day 0) and then after 7 days (Day 7) and then after 14 days (Day 14).
- Secondary Outcome Measures
Name Time Method ot applicableTimepoint: Not applicable